SpringerLink
Log in

Letter to the Editor: Lazzaro responds to Kennedy et al.

  • Commentary
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

The Original Article was published on 27 February 2024

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Not applicable.

Code availability

Not applicable.

References

  1. Kennedy, K., Sarohia, G., Podbielski, D., Pickard, S., Tarride, J.E., **e, F.: Systematic methodological review of health state values in glaucoma cost-utility analyses. Eur. J. Health Econ. (2024). https://doi.org/10.1007/s10198-023-01663-x

    Article  PubMed  Google Scholar 

  2. Annemans, L., Genesté, B., Jolain, B.: Early modelling for assessing health and economic outcomes of drug therapy. Value Health. 3, 427–434 (2000). https://doi.org/10.1046/j.1524-4733.2000.36007.x

    Article  CAS  PubMed  Google Scholar 

  3. IJzerman, M.J., Koffijberg, H., Fenwick, E., Krahn, M.: Emerging use of early health technology assessment in medical product development: A sco** review of the literature. Pharmacoeconomics. 35, 727–740 (2017). https://doi.org/10.1007/s40273-017-0509-1

    Article  PubMed  PubMed Central  Google Scholar 

  4. Drummond, M.F., Sculpher, M.J., Claxton, K., Stoddart, G.L., Torrance, G.W.: Methods for the Economic Evaluation of Health care Programmes, 4th edn. Oxford University Press, Oxford (2015)

    Google Scholar 

  5. Neumann, P.J., Sanders, G.D., Russell, L.B., Siegel, J.E., Ganiats, T.G. (eds.): Cost-effectiveness in Health and Medicine, 2nd edn. Oxford University Press, New York (2016)

    Google Scholar 

  6. Lazzaro, C., van Steen, C., Billeit, S., Frauenknecht, H., Kallen, C., Pfennigsdorf, S., Thelen, U., Angelillo, L.: Cost-utility analysis of a latanoprost cationic emulsion (STN1013001) versus other latanoprost in the treatment of open-angle glaucoma or ocular hypertension and concomitant ocular surface disease in Germany. Clin. Ophthalmol. 16, 323–337 (2022). https://doi.org/10.2147/OPTH.S351013

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lazzaro, C., van Steen, C., Aptel, F., Schweitzer, C., Angelillo, L.: Cost-utility analysis of STN1013001, a latanoprost cationic emulsion, versus other latanoprost formulations (latanoprost) in open-angle glaucoma or ocular hypertension and ocular surface disease in France. J. Ophthalmol. (2022). https://doi.org/10.1155/2022/3837471

    Article  PubMed  PubMed Central  Google Scholar 

  8. Patel, V., Ahmed, I., Podbielski, D., Falvey, H., Murray, J., Goeree, R.: Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada. J. Med. Econ. 22(4), 390–401 (2019). https://doi.org/10.1080/13696998.2019.1572013

    Article  PubMed  Google Scholar 

  9. Ordóñez, J.E., Ordóñez, A., Osorio, U.M.: Cost-effectiveness analysis of iStent trabecular micro-bypass stent for patients with open-angle glaucoma in Colombia. Curr. Med. Res. Opin. 35(2), 329–340 (2019). https://doi.org/10.1080/03007995.2018.1506022

    Article  PubMed  Google Scholar 

  10. van Gestel, A., Webers, C.A., Severens, J.L., Beckers, H.J., Jansonius, N.M., Hendrikse, F., Schouten, J.S.: The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma. Acta Ophthalmol. 90, 20–31 (2012). https://doi.org/10.1111/j.1755-3768.2011.02318.x

    Article  PubMed  Google Scholar 

  11. O’Hagan, A., Buck, C.E., Daneshkhah, A., Eiser, J.R., Garthwaite, P.H., Jenkinson, D.J., Oakley, J.E., Rakow, R.: Uncertain Judgements: Eliciting Experts’ Probabilities. Wiley, Chichester (2006)

    Book  Google Scholar 

  12. McAteer, H., Cosh, E., Freeman, G., Pandit, A., Wood, P., Lilford, R.: Cost-effectiveness analysis at the development phase of a potential health technology: Examples based on tissue engineering of bladder and urethra. J. Tissue Eng. Regen Med. 1, 343–349 (2007). https://doi.org/10.1002/term.36

    Article  CAS  PubMed  Google Scholar 

  13. Girling, A., Young, T., Brown, C., Lilford, R.: Early-stage valuation of medical devices: The role of developmental uncertainty. Value Health. 13, 585–591 (2010). https://doi.org/10.1111/j.1524-4733.2010.00726.x

    Article  PubMed  Google Scholar 

Download references

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Health Economist and Research Director, Studio di Economia Sanitaria, Via Stefanardo da Vimercate, 19, Milan, 20128, Italy

    Carlo Lazzaro

  2. Biology and Biotechnologies Department “Lazzaro Spallanzani”, University of Pavia, Pavia, 27100, Italy

    Carlo Lazzaro

Authors
  1. Carlo Lazzaro
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Carlo Lazzaro drafted this Letter to the Editor.

Corresponding author

Correspondence to Carlo Lazzaro.

Ethics declarations

Conflict of interest

Carlo Lazzaro has no conflicts of interest/competing interests with this Letter to the Editor. Outside this Letter to the Editor, in the past three years Carlo Lazzaro has received teaching fees from University of Pavia, research grants, speaker or consultancy fees from argenx BV, AstraZeneca S.p.A, Ipsen S.p.A., Janssen-Cilag SPA, Horizon Therapeutics srl, Roche S.p.A., Roche Diagnostics S.p.A., Sanofi s.r.l., Santen GmbH.

Declaration of generative Artificial Intelligence in scientific writing

Carlo Lazzaro declares that no section of this Letter to the Editor was supported by Artificial Intelligence.

Ethical approval

This contribution was exempt from ethical review due to it being a Letter to the Editor.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lazzaro, C. Letter to the Editor: Lazzaro responds to Kennedy et al.. Eur J Health Econ (2024). https://doi.org/10.1007/s10198-024-01703-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10198-024-01703-0

JEL Classification

Search

Navigation